Related Experiment Video
Updated: Feb 24, 2026

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Published on: January 20, 2023
From Vaccines to Therapeutics: The Need for Distinct mRNA-LNP Design Principles
1Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P. R. China.
Abstract:
Therapeutic mRNA-LNPs require design principles distinct from vaccines. Optimizing ionizable lipids, modifying or replacing PEG-lipids, and applying rational molecular design can improve immune compatibility, safety, and repeated-dose efficacy. These strategies reduce toxicity, unintended immune activation, and accelerated blood clearance, unlocking the full therapeutic potential of mRNA-LNPs beyond the vaccine paradigm.
Related Concept Videos
Leaky Scanning
Microorganisms in Medicine and Therapeutics
Nucleic Acid Structure
DNA Structure
DNA...
lncRNA - Long Non-coding RNAs
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...

